Follow
Kei KUDO
Title
Cited by
Cited by
Year
Biosynthetic origin of the hydroxamic acid moiety of trichostatin A: identification of unprecedented enzymatic machinery involved in hydroxylamine transfer
K Kudo, T Ozaki, K Shin-Ya, M Nishiyama, T Kuzuyama
Journal of the American Chemical Society 139 (20), 6799-6802, 2017
342017
In vitro Cas9-assisted editing of modular polyketide synthase genes to produce desired natural product derivatives
K Kudo, T Hashimoto, J Hashimoto, I Kozone, N Kagaya, R Ueoka, ...
Nature communications 11 (1), 4022, 2020
292020
Comprehensive derivatization of thioviridamides by heterologous expression
K Kudo, H Koiwai, N Kagaya, M Nishiyama, T Kuzuyama, K Shin-Ya, ...
ACS Chemical Biology 14 (6), 1135-1140, 2019
132019
An atypical arginine dihydrolase involved in the biosynthesis of cyclic hexapeptide longicatenamides
C Liu, J Hashimoto, K Kudo, K Shin‐ya, H Kakeya
Chemistry–An Asian Journal 16 (11), 1382-1387, 2021
22021
Hemiacetal-less rapamycin derivatives designed and produced by genetic engineering of a type I polyketide synthase
K Kudo, T Nishimura, I Kozone, J Hashimoto, N Kagaya, H Suenaga, ...
Scientific reports 11 (1), 9944, 2021
12021
Method for producing compound with modified mother nucleus
K Shinya, H Ikeda, M Komatsu, J Hashimoto, I Kozone, T Hashimoto, ...
US Patent App. 17/426,621, 2022
2022
A novel methymycin analog, 12-ketomethymycin N-oxide, produced by the heterologous expression of the large pikromycin/methymycin biosynthetic gene cluster of Streptomyces sp …
R Ueoka, J Hashimoto, I Kozone, T Hashimoto, K Kudo, N Kagaya, ...
Bioscience, Biotechnology, and Biochemistry 85 (4), 890-894, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–7